Education
About Us
Working with TipRanks
Follow Us
Lisa von Moltke Insider Profile
4 Followers
Lisa von Moltke, EVP and Chief Medical Officer at Seres Therapeutics, holds 39.88K shares in Seres Therapeutics (Ticker: MCRB), holds 183.01K shares in Tvardi Therapeutics (Ticker: TVRD), holds ― shares in Zenas BioPharma, Inc. (Ticker: ZBIO).
Lisa von Moltke has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lisa von Moltke holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Lisa von Moltke
Lisa von Moltke's Trading History
Seres Therapeutics
Feb 19, 2025
EVP and Chief Medical Officer
Uninformative Buy
6.21K
$552.27K
Tvardi Therapeutics
Jun 06, 2024
Director
Uninformative Buy
―
$4.74M
Zenas BioPharma, Inc.
―
See Remarks
―
―
List of latest transactions for each holding click on a transaction to see Lisa von Moltke's performance on stock
You May Also Like
Lisa von Moltke insider profile FAQ
What is the percentage of profitable transactions made by Lisa von Moltke?
The percentage of profitable transactions made by Lisa von Moltke is ―.
What is the average return per transaction made by Lisa von Moltke?
The average return per transaction made by Lisa von Moltke is ―.
What stocks does Lisa von Moltke hold?
Lisa von Moltke holds: MCRB, TVRD, ZBIO stocks.
What was Lisa von Moltke’s latest transaction?
Lisa von Moltke latest transaction was an Uninformative Buy of $6.21K.
What was Lisa von Moltke's most profitable transaction?
Lisa von Moltke’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Lisa von Moltke's role in Seres Therapeutics?
Lisa von Moltke's role in Seres Therapeutics is EVP and Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.